Cognitive Disorders in Patients with Chronic Kidney Disease: Specificities of Clinical Assessment

Overview

Journal Nephrol Dial Transplant

Publisher Oxford University Press

Specialties General Surgery
Nephrology

Date 2021 Oct 31

PMID 34718757

Citations 22

Authors

Marion Pepin

Ana Carina Ferreira

Mustafa Arici

Maie Bachman

Michelangela Barbieri

Inga Arune Bumblyte

Sol Carriazo

Pilar Delgado

Liliana Garneata

Konstantinos Giannakou

Olivier Godefroy

Tomasz Grodzicki

Aleksandra Klimkowicz-Mrowiec

Justina Kurganaite

Sophie Liabeuf

Carmen Antonia Mocanu

Giuseppe Paolisso

Goce Spasovski

Evgueniy Stefanov Vazelov

Davide Viggiano

Carmine Zoccali

Ziad A Massy

Andrzej Wiecek

Affiliations

Soon will be listed here.

Abstract

Neurocognitive disorders are frequent among chronic kidney disease (CKD) patients. Identifying and characterizing cognitive impairment (CI) can help to assess the ability of adherence to CKD risk reduction strategy, identify potentially reversible causes of cognitive decline, modify pharmacotherapy, educate the patient and caregiver and provide appropriate patient and caregiver support. Numerous factors are associated with the development and progression of CI in CKD patients and various conditions can influence the results of cognitive assessment in these patients. Here we review clinical warning signs that should lead to cognitive screening; conditions frequent in CKD at risk to interfere with cognitive testing or performance, including specificities of cognitive assessment in dialysis patients or after kidney transplantation; and available tests for screening and observed cognitive patterns in CKD patients.

Citing Articles

Cognitive Impairment in Chronic Kidney Disease Across Different Stages: The Role of Structural and Perfusion-Driven Functional Connectivity Changes.

Bai X, Song L, Liu X, Yang W, Li M, Xu B Brain Behav. 2025; 15(2):e70330.

PMID: 39957426 PMC: 11830999. DOI: 10.1002/brb3.70330.

Screening for cognitive symptoms in dialysis patients with an extended version of Kidney Disease Quality of Life Cognitive Function subscale (KDQOL-CF): a validation study.

Chan F, Sim P, Lim P, Khan B, Choo J, Griva K BMC Nephrol. 2024; 25(1):434.

PMID: 39609776 PMC: 11606010. DOI: 10.1186/s12882-024-03848-9.

How to make a shared decision with older persons for end-stage kidney disease treatment: the added value of geronto-nephrology.

Guerville F, Pepin M, Garnier-Crussard A, Beuscart J, Citarda S, Hocine A Clin Kidney J. 2024; 17(10):sfae281.

PMID: 39372237 PMC: 11450468. DOI: 10.1093/ckj/sfae281.

Association between cognitive functioning and health-related quality of life and its mediation by depressive symptoms in older patients with kidney failure.

Demirhan I, van Oevelen M, Skalli Z, Voorend C, Mooijaart S, Meuleman Y J Nephrol. 2024; 37(7):1939-1948.

PMID: 39327357 PMC: 11519205. DOI: 10.1007/s40620-024-02095-3.

Cognitive Dysfunction Screening in Peritoneal Dialysis Patients: A Cross-Sectional Study.

Bras A, Marques J, Fernandes V, Ferreira A Indian J Nephrol. 2024; 34(4):357-362.

PMID: 39156843 PMC: 11326789. DOI: 10.25259/ijn_378_23.

References

Zhou H, Al-Ali F, Wang C, Hamad A, Ibrahim R, Talal T . Harnessing digital health to objectively assess cognitive impairment in people undergoing hemodialysis process: The Impact of cognitive impairment on mobility performance measured by wearables. PLoS One. 2020; 15(4):e0225358. PMC: 7170239. DOI: 10.1371/journal.pone.0225358. View

Jurgensen A, Qannus A, Gupta A . Cognitive Function in Kidney Transplantation. Curr Transplant Rep. 2020; 7:145-153. PMC: 7473337. DOI: 10.1007/s40472-020-00284-0. View

Cerami A, Brines M, Ghezzi P, Cerami C, Itri L . Neuroprotective properties of epoetin alfa. Nephrol Dial Transplant. 2002; 17 Suppl 1:8-12. DOI: 10.1093/ndt/17.suppl_1.8. View

Puy L, Bugnicourt J, Liabeuf S, Desjardins L, Roussel M, Diouf M . Cognitive Impairments and Dysexecutive Behavioral Disorders in Chronic Kidney Disease. J Neuropsychiatry Clin Neurosci. 2018; 30(4):310-317. DOI: 10.1176/appi.neuropsych.18030047. View

Sachdev P, Mohan A, Taylor L, Jeste D . DSM-5 and Mental Disorders in Older Individuals: An Overview. Harv Rev Psychiatry. 2015; 23(5):320-8. PMC: 4562208. DOI: 10.1097/HRP.0000000000000090. View

Finkelstein F, Finkelstein S . Depression in chronic dialysis patients: assessment and treatment. Nephrol Dial Transplant. 2000; 15(12):1911-3. DOI: 10.1093/ndt/15.12.1911. View

Siqueira G, Hagemann P, Coelho D, Santos F, Bertolucci P . Can MoCA and MMSE Be Interchangeable Cognitive Screening Tools? A Systematic Review. Gerontologist. 2018; 59(6):e743-e763. DOI: 10.1093/geront/gny126. View

DeCarli C . The role of cerebrovascular disease in dementia. Neurologist. 2003; 9(3):123-36. DOI: 10.1097/00127893-200305000-00001. View

Khouri Y, Stephens T, Ayuba G, AlAmeri H, Juratli N, McCullough P . Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease. J Atr Fibrillation. 2016; 7(6):1069. PMC: 4956356. DOI: 10.4022/jafib.1069. View

10.

Eisenstaedt R, Penninx B, Woodman R . Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 2006; 20(4):213-26. DOI: 10.1016/j.blre.2005.12.002. View

11.

Sehgal A, Grey S, DeOreo P, Whitehouse P . Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997; 30(1):41-9. DOI: 10.1016/s0272-6386(97)90563-1. View

12.

Vermeer S, den Heijer T, Koudstaal P, Oudkerk M, Hofman A, Breteler M . Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003; 34(2):392-6. DOI: 10.1161/01.str.0000052631.98405.15. View

13.

Kurella Tamura M, Tam K, Vittinghoff E, Raj D, Sozio S, Rosas S . Inflammatory Markers and Risk for Cognitive Decline in Chronic Kidney Disease: The CRIC Study. Kidney Int Rep. 2017; 2(2):192-200. PMC: 5399682. DOI: 10.1016/j.ekir.2016.10.007. View

14.

Nakatani T, Naganuma T, Uchida J, Masuda C, Wada S, Sugimura T . Silent cerebral infarction in hemodialysis patients. Am J Nephrol. 2002; 23(2):86-90. DOI: 10.1159/000068034. View

15.

Gupta A, Lepping R, Yu A, Perea R, Honea R, Johnson D . Cognitive Function and White Matter Changes Associated with Renal Transplantation. Am J Nephrol. 2016; 43(1):50-7. PMC: 5870800. DOI: 10.1159/000444334. View

16.

Prado C, Crowe S . Corticosteroids and Cognition: A Meta-Analysis. Neuropsychol Rev. 2019; 29(3):288-312. DOI: 10.1007/s11065-019-09405-8. View

17.

Quinn M, Cardwell C, Kee F, Maxwell A, Savage G, McCarron P . The finding of reduced estimated glomerular filtration rate is associated with increased mortality in a large UK population. Nephrol Dial Transplant. 2010; 26(3):875-80. DOI: 10.1093/ndt/gfq505. View

18.

Paraizo M, Almeida A, Pires L, Abrita R, Crivellari M, Pereira B . Montreal Cognitive Assessment (MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) pre-dialysis. J Bras Nefrol. 2016; 38(1):31-41. DOI: 10.5935/0101-2800.20160006. View

19.

Fine A . Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int. 2002; 61(2):615-20. DOI: 10.1046/j.1523-1755.2002.00145.x. View

20.

Diener H, Hart R, Koudstaal P, Lane D, Lip G . Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 73(5):612-619. DOI: 10.1016/j.jacc.2018.10.077. View